People · Operator
Named in public records as an officer, director or promoter · active 2012–2017 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Invitae Corp | — | Biotechnology | Series C | $203.1M | $2.1B | 2012 |
| Bryte, Inc. | — | Other Technology | Series B | $18.5M | $447.3M | 2017 |
Richard Tompane at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Tompane on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Walsh | 1 | 7 |
| Randal Scott | 1 | 4 |
| Eric Aguiar | 1 | 3 |
| Ely Tsern | 1 | 2 |
| Anya Schiess | 1 | 2 |
| CHRISTINE GORJANC | 1 | 2 |
| Geoffrey Crouse | 1 | 1 |
| Sean George | 1 | 1 |
| Lee Bendekgey | 1 | 1 |
| John Tompane | 1 | 1 |
| Jonathan Farringdon | 1 | 1 |
| Shelly Guyer | 1 | 1 |
| Chitra Nayak | 1 | 1 |
| Michele Cargill | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.